What is the best treatment for onychomycosis (nail fungus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Onychomycosis (Nail Fungus)

Oral terbinafine is the most effective first-line treatment for onychomycosis, with superior cure rates compared to other therapies. 1

Treatment Selection Algorithm

First-Line Treatment

  • Oral terbinafine (250 mg daily) is recommended as first-line therapy for moderate to severe onychomycosis caused by dermatophytes 1, 2
    • Treatment duration: 6 weeks for fingernails, 12-16 weeks for toenails 1
    • Highest mycological cure rates (70-80% for toenails, 80-90% for fingernails) 1
    • Fungicidal action provides better long-term outcomes with lower relapse rates compared to itraconazole (23% vs 53% relapse) 1

Alternative Systemic Treatments

  • Itraconazole (200 mg daily continuous or 400 mg pulse therapy for 1 week per month) is the second-best alternative when terbinafine is contraindicated 1

    • Pulse therapy: 2 pulses for fingernails, 3 pulses for toenails 1
    • Preferred for Candida onychomycosis 1
  • Fluconazole (450 mg weekly) can be used when other systemic options are not tolerated 1

    • Less effective than terbinafine or itraconazole but better compliance with weekly dosing 1
    • Treatment duration: 3 months for fingernails, 6+ months for toenails 1

Topical Treatments

Indicated for:

  • Mild to moderate disease (< 80% nail involvement)
  • No lunula involvement
  • When systemic antifungals are contraindicated 1

Options include:

  • Amorolfine 5% lacquer: Applied once or twice weekly for 6-12 months, ~50% efficacy 1
  • Ciclopirox 8% lacquer: Applied daily for up to 48 weeks, 34% mycological cure rate 1, 3
  • Efinaconazole 10%: Once daily application, ~50% mycological cure rate 1

Special Populations

Pediatric Patients

  • Prevalence < 0.5% in children 1
  • Terbinafine is recommended based on weight:
    • 62.5 mg/day if < 20 kg
    • 125 mg/day for 20-40 kg
    • 250 mg/day if > 40 kg 1
  • Itraconazole pulse therapy (5 mg/kg/day for 1 week monthly) is an alternative 1
  • Treatment duration: 6 weeks for fingernails, 12 weeks for toenails 1

Candida Onychomycosis

  • Itraconazole is most effective for Candida nail infections 1
  • Same dosage as for dermatophytes: 400 mg daily for 1 week per month, 2 pulses for fingernails 1

Treatment Failure Management

Common causes of treatment failure include:

  • Poor compliance
  • Poor drug absorption
  • Immunosuppression
  • Dermatophyte resistance
  • Subungual dermatophytoma preventing drug penetration 1

Management options:

  • Switch to alternative antifungal agent
  • Partial nail removal combined with antifungal therapy 1
  • Consider combination therapy (topical + systemic) for synergistic effect 1

Prevention of Recurrence

  • Recurrence rates are high (20-30%) even after successful treatment 1, 4
  • Preventive measures include:
    • Avoiding walking barefoot in public places 4
    • Disinfecting shoes and socks 4
    • Treating concurrent tinea pedis 5
    • Consider prophylactic use of amorolfine 1

Important Caveats

  • Always confirm diagnosis with laboratory testing (KOH preparation, fungal culture, or nail biopsy) before initiating treatment 1, 2
  • Monitor for drug-drug interactions, especially with terbinafine and medications like tricyclic antidepressants, SSRIs, beta blockers 4
  • Clinical improvement may not correlate with mycological cure, which is often 30% lower than clinical improvement rates 1
  • Treatment should be continued for the full recommended duration even if visual improvement occurs early 4, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Onychomycosis: Rapid Evidence Review.

American family physician, 2021

Research

Current and emerging options in the treatment of onychomycosis.

Seminars in cutaneous medicine and surgery, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.